Reinfection Following Successful DAA Therapy for HCV Among People With Recent Injecting Drug Use: The SHARP-C Study – hepCoalition

Reinfection Following Successful DAA Therapy for HCV Among People With Recent Injecting Drug Use: The SHARP-C Study – hepCoalition

A study evaluated the incidence of HCV reinfection following successful direct acting antiviral therapy among people with recent injecting drug use. Prevention / People who use drugs, Harm reduction